Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

CHIRHOSTIM

SECRETIN SYNTHETIC HUMAN

Standard Dose
16MCG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CHIRHOSTIM is listed in Drugs@FDA under application 021256 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SECRETIN SYNTHETIC HUMAN Form and strength FOR SOLUTION;INTRAVENOUS - 16MCG/VIAL Sponsor CHIRHOCLIN Submission history Latest submission status date: 2017-07-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview CHIRHOSTIM is listed in Drugs@FDA under application 021256 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SECRETIN SYNTHETIC HUMAN Form and strength FOR SOLUTION;INTRAVENOUS - 16MCG/VIAL Sponsor CHIRHOCLIN Submission history Latest submission status date: 2017-07-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.